Genus β human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: Population based case-control study

BMJ (Online)

Volumn 341, Issue 7767, 2010, Pages 290-

  Karagas, Margaret R ^a   Waterboer, Tim ^b   Li, Zhongze ^a   Nelson, Heather H ^c   Michael, Kristina M ^b   Bavinck, Jan Nico Bouwes ^d   Perry, Ann E ^a   Spencer, Steven K ^a   Daling, Janet ^e   Green, Adele C ^f   Pawlita, Michael ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF MINNESOTA   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF WASHINGTON   (United States)

^f ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; VIRUS ANTIBODY;

ADULT; AGED; ALLERGY; ARTICLE; ASTHMA; BASAL CELL CARCINOMA; BETAPAPILLOMAVIRUS; BLOOD SAMPLING; CANCER INCIDENCE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NONHUMAN; PAPILLOMAVIRUS INFECTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SEROLOGY; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; UNITED STATES; VIRUS GENOME; BLOOD; CASE CONTROL STUDY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INCIDENCE; MIDDLE AGED; RISK FACTOR; SKIN TUMOR; VIROLOGY;

ADULT; AGED; ANTIBODIES, VIRAL; BETAPAPILLOMAVIRUS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNE TOLERANCE; INCIDENCE; MALE; MIDDLE AGED; NEW HAMPSHIRE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SKIN NEOPLASMS;

EID: 77955375491     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c2986     Document Type: Article

References (32)

1. Karagas MR, Weinstock MA, Nelson HH. Keratinocyte carcinomas (basal and squamous cell carcinomas of the skin). In: Schottenfeld DFJF Jr, ed. Cancer epidemiology and prevention. 3rd ed. Oxford University Press, 2006.
2. De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004;324:17-27.
3. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: human papillomaviruses. Vol 90. IARC, 2007.
4. Bouwes Bavinck JN, Stark S, Petridis AK, Marugg ME, Ter Schegget J, Westendorp RG, et al. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated humanpapillomavirus type 8 in patients with actinic keratoses. Br J Dermatol 2000;142:103-9.
5. Feltkamp MC, Broer R, di Summa FM, Struijk L, van der Meijden E, Verlaan BP, et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 2003;63:2695-700.
6. Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006;98:389-95.
7. Masini C, Fuchs PG, Gabrielli F, Stark S, Sera F, Ploner M, et al. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals. Arch Dermatol 2003;139:890-4.
8. Stark S, Petridis AK, Ghim S, Jenson AB, Bouwes Bavinck JN, Gross G, et al. Prevalence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol 1998;111:696-701. (Pubitemid 28452336)
9. Steger G, Olszewsky M, Stockfleth E, Pfister H. Prevalence of antibodies to human papillomavirus type 8 in human sera. J Virol 1990;64:4399-406.
10. Struijk L, Hall L, van der Meijden E, Wanningen P, Bavinck JN, Neale R, et al. Markers of cutaneous human papillomavirus infection in individuals with tumor-free skin, actinic keratoses, and squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:529-35.
11. Waterboer T, Abeni D, Sampogna F, Rother A, Masini C, Sehr P, et al. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Br J Dermatol 2008;159:457-9.
12. Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. J Natl Cancer Inst 1996;88:1848-53.
13. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int J Cancer 1999;81:555-9.
14. Kricker A, Armstrong BK, English DR. Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 1994;5:367-92.
15. Kricker A, Armstrong BK, English DR, Heenan PJ. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer - a case-control study. Int J Cancer 1991;48:650-62.
16. Sehr P, Muller M, Hopfl R, Widschwendter A, Pawlita M. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods 2002;106:61-70. (Pubitemid 35279650)
17. Sehr P, Zumbach K, Pawlita M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 2001;253:153-62.
18. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland J, Joos TO, et al. Multiplex human papillomavirus serology based on in situpurified glutathione s-transferase fusion proteins. Clin Chem 2005;51:1845-53.
19. Michael KM, Waterboer T, Sehr P, Rother A, Reidel U, Boeing H, et al. Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 2008;4:e1000091.
20. Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, et al. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 2008;17:1731-8.
21. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1 - the analysis of case-control studies. IARC, 1980.
22. Miettinen O. Estimability and estimation in case-referent studies.Am J Epidemiol 1976;103:226-35.
23. Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, et al. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 2001;153:559-65.
24. Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, et al. A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin.N Engl J Med 1990;323:789-95.
25. Andersson K, Waterboer T, Kirnbauer R, Slupetzky K, Iftner T, de Villiers EM, et al. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions. Cancer Epidemiol Biomarkers Prev 2008;17:189-95.
26. Casabonne D, Michael KM, Waterboer T, Pawlita M, Forslund O, Burk RD, et al. A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007;121:1862-8.
27. Nindl I, Gottschling M, Stockfleth E. Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers 2007;23:247-59.
28. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O'Sullivan B, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996;61:715-21.
29. Karagas MR, Cushing GL Jr, Greenberg ER, Mott LA, Spencer SK, Nierenberg DW. Risk of non-melanoma skin cancer associated with glucocorticoid therapy. Br J Cancer 2001;85:683-6.
30. Sorensen HT, Mellemkjor L, Nielsen GL, Baron JA, Olsen JH, Karagas MR. Risk of skin cancers and malignant lymphomas among users of systemic glucocorticoids: a population-based cohort study. J Nat Cancer Inst 2004;96:709-11.
31. Underbrink MP, Howie HL, Bedard KM, Koop JI, Galloway DA. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J Virol 2008;82:10408-17.
32. Karagas MR, Zens MS, Nelson HH, Mabuchi K, Perry AE, Stukel TA, et al. Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage. Am J Epidemiol 2007;165:719-26.